AAAAAA

   
Results: 1-14 |
Results: 14

Authors: TUBERTBITTER P HARAMBURU F BEGAUD B CHASLERIE A ABRAHAM E HAGRY C
Citation: P. Tubertbitter et al., SPONTANEOUS REPORTING OF ADVERSE DRUG-REACTIONS - WHO REPORTS AND WHAT, Pharmacoepidemiology and drug safety, 7(5), 1998, pp. 323-329

Authors: BAUMEVIEILLE M HARAMBURU F BEGAUD B
Citation: M. Baumevieille et al., ABUSE OF PRESCRIPTION MEDICINES IN SOUTHWESTERN FRANCE, The Annals of pharmacotherapy, 31(7-8), 1997, pp. 847-850

Authors: MOORE N KREFTJAIS C HARAMBURU F NOBLET C ANDREJAK M OLLAGNIER M BEGAUD B
Citation: N. Moore et al., REPORTS OF HYPOGLYCEMIA ASSOCIATED WITH THE USE OF ACE-INHIBITORS ANDOTHER DRUGS - A CASE NON-CASE STUDY IN THE FRENCH PHARMACOVIGILANCE SYSTEM DATABASE/, British journal of clinical pharmacology, 44(5), 1997, pp. 513-518

Authors: HARAMBURU F BEGAUD B MORIDE Y
Citation: F. Haramburu et al., TEMPORAL TRENDS IN SPONTANEOUS REPORTING OF UNLABELED ADVERSE DRUG-REACTIONS, British journal of clinical pharmacology, 44(3), 1997, pp. 299-301

Authors: MORIDE Y HARAMBURU F REQUEJO AA BEGAUD B
Citation: Y. Moride et al., UNDER-REPORTING OF ADVERSE DRUG-REACTIONS IN GENERAL-PRACTICE, British journal of clinical pharmacology, 43(2), 1997, pp. 177-181

Authors: TUBERTBITTER P BEGAUD B MORIDE Y CHASLERIE A HARAMBURU F
Citation: P. Tubertbitter et al., COMPARING THE TOXICITY OF 2 DRUGS IN THE FRAMEWORK OF SPONTANEOUS REPORTING - A CONFIDENCE-INTERVAL APPROACH, Journal of clinical epidemiology, 49(1), 1996, pp. 121-123

Authors: AGUIRRE C HARAMBURU F
Citation: C. Aguirre et F. Haramburu, DRUG SURVEILLANCE IN FRANCE AND SPAIN - C OMPARISON OF SPONTANEOUS REPORTING IN 2 REGIONAL CENTERS, Therapie, 50(6), 1995, pp. 563-569

Authors: HARAMBURU F LINDOULSI T BAVOUX F BOYER M BEGAUD B BARAT C MAGNE F DELAGE F PERE JC
Citation: F. Haramburu et al., STRATEGY OF TREATMENT OF PRURITUS DURING PREGNANCY, The Annals of pharmacotherapy, 28(1), 1994, pp. 17-20

Authors: BEGAUD B CHASLERIE A HARAMBURU F
Citation: B. Begaud et al., ORGANIZATION AND RESULTS OF PHARMACOVIGIL ANCE IN FRANCE, Revue d'epidemiologie et de sante publique, 42(5), 1994, pp. 416-423

Authors: BEGAUD B CHASLERIE A HARAMBURU F
Citation: B. Begaud et al., ORGANIZATION AND RESULTS OF PHARMACOVIGIL ANCE IN FRANCE, Revue d'epidemiologie et de sante publique, 42(5), 1994, pp. 416-423

Authors: BEGAUD B MORIDE Y TUBERTBITTER P CHASLERIE A HARAMBURU F
Citation: B. Begaud et al., FALSE-POSITIVES IN SPONTANEOUS REPORTING - SHOULD WE WORRY ABOUT THEM, British journal of clinical pharmacology, 38(5), 1994, pp. 401-404

Authors: MIREMONT G HARAMBURU F BEGAUD B PERE JC DANGOUMAU J
Citation: G. Miremont et al., ADVERSE DRUG-REACTIONS - PHYSICIANS OPINIONS VERSUS A CAUSALITY ASSESSMENT METHOD, European Journal of Clinical Pharmacology, 46(4), 1994, pp. 285-289

Authors: HARAMBURU F MIREMONT G CHASLERIE A BEGAUD B DANGOUMAU J
Citation: F. Haramburu et al., EFFICIENCY OF MEDICAL JOURNALS FOR PHARMACOVIGILANCE, Lancet, 341(8851), 1993, pp. 1030-1031

Authors: HARAMBURU F ABRAHAM E BEGAUD B
Citation: F. Haramburu et al., USERS OF A REGIONAL PHARMACOVIGILANCE CEN TER, Therapie, 48(5), 1993, pp. 475-477
Risultati: 1-14 |